China

Life Sciences and Healthcare 

China's government has ambitious plans to achieve equal access to public healthcare for all its citizens by 2020. This will not only mean a decade of change throughout public and private healthcare institutions, but healthcare's supporting industries, from pharmaceutical to medical equipment manufacturers, are set for a period of major restructuring.

Norbert Meyring

Norbert Meyring

Head of Life Sciences and Healthcare

+86 (21) 2212 2888

Peter Wong

Peter Wong

Partner

+852 2826 7152

Li Fern Woo

Li Fern Woo

Partner

+86 (21) 2212 2603

KPMG China is committed to providing long term support to our clients as they tackle these challenges and seek to transform the way that healthcare is provided.

 

With deep industry experience, insight and technical support, we are among the leaders in delivering a broad range of Audit, Tax and Advisory services to meet the unique needs of healthcare policy-makers, providers and payers.